We report a case of synchronous double primary vulvar cancer and renal cell carcinoma. Kidney mass was incidentally detected during preoperative evaluation of vulvar cancer, and was finally confirmed as a renal cell carcinoma. Although the initial result of 18F-fluorodeoxyglucose positron emission tomography was negative for a renal malignancy, nephrectomy was performed under the radiological and urologic impression of renal cell carcinoma which was supported by computerized tomography findings. Histological analysis finally confirmed a renal cell carcinoma. This is the first case report of synchronous double primary vulvar cancer and renal cell carcinoma, which emphasizes multidisciplinary approach to unexpected lesions when the clinical experience of one specialist is limited.
INTRODUCTION
As the use of computerized tomography (CT) in preoperative investigation of patients with gynecologic malignancy has been widely used, the frequency of incidental detection of other abdominal or pelvic mass increased. However, since the incidence of vulvar cancer itself is very low, 1 surgical treatment for the vulvar cancer. Under the suspicion of renal malignancy, right nephrectomy was also performed by urologist. On pathologic examination, the right kidney mass was diagnosed as an RCC (Fig. 2 ). However, it is cumbersome for physicians to determine a therapeutic plan in cases showing discordant results between PET and other imaging studies. Furthermore, when it comes to non-gynecologic diseases it is more difficult for gynecologists to make an appropriate decision.
DISCUSSION
Here we report a case of incidentally detected kidney mass during preoperative evaluation of vulvar cancer, which was finally confirmed as a renal cell carcinoma.
It has been known that the initial diagnosis of renal mass is usually made with ultrasound, CT, or MRI. 2 Most cases (70%) are discovered incidentally during CT-imaging procedures for other purposes. 2 It was also reported that around 20% of these masses are benign tumors (eg, oncocytoma and fat-poor angiomyolipoma), 25% are indolent tumors with limited metastatic potential (eg, papillary and chromophobe carcinoma), and 54% represent the more potentially malignant conventional clear-cell carcinoma that uncommonly achieves its metastatic potential at a size of 4 cm or less. 3 Although benign, indolent, and malignant renal cortical tumors can display growth over time, metastatic potential is intrinsic to the histological subtype. Around 90% of patients who present with, or later develop, metastatic renal cancer have the clear-cell histological subtype. 4 Renal biopsy is rarely done for a localized kidney tumor because of inaccuracy and ineffectiveness in clinical management. Surgical removal is the treatment of choice in this situation, and partial nephrectomy provides equivalent tumor control to radical nephrectomy. 5 Partial nephrectomy is a legitimate option for tumors up to 7 cm in size, especially if they are exophytic. 6 The role of FDG-PET in urological tumor is still under investigation with no final conclusion. 7 Imaging of malignant renal tumors is regarded as more difficult than those of other tumors because of the renal elimination of F-18FDG. 8 Therefore the negative FDG-PET does not exclude renal malignancy. In terms of FDG-PET sensitivity in diabetic subject, as in the current case, it has been reported that high blood glucose levels interfere with FDG uptake in malignant lesions. 9 Although the glucose transporters are overexpressed in malignant cells, they can be saturated and the presence of excess unlabeled glucose has been shown in animal models to markedly reduce FDG uptake in tumors. 10 Recently, some authors reported high sensitivity (94%) and specificity (100%) of the "Immuno-PET" using iodine-124-labelled antibody chimeric G250 (124I-cG250) overcoming the pitfall of the conventional PET in diagnosis of renal cell carcinoma. 11 As the radiographic modalities evolve and improve, it is not uncommon for gynecologists to encounter incidental lesions during pretreatment evaluation of gynecologic cancer patients. The case presented here has its interest in that it emphasizes multidisciplinary approach to unexpected lesions when the clinical experience of one specialist is limited.
